Welcome to CGX Genetic Cancer Lab!
It is estimated that there were
1,762,450 new cancer cases diagnosed in the United States last year!
606,880 people died from cancer in the United States last year!
That is 1,663 people dying from cancer EVERY DAY and 4,829 people EVERY DAY being diagnosed with cancer in the United States alone!
Our website is dedicated to helping people to find out if they carry the cancer gene which can not only impact your life, but also the lives of your children, your grandchildren, and your siblings. Even if you or your parents currently have or have had cancer in the past, knowing if you carry the cancer gene can give your family the opportunity to be checked BEFORE they get cancer to see if you or your parents have passed the gene on to them.
We offer a No Cost / No Obligation survey to see if you qualify for a Heart / Cancer / Prescription Drug Interaction genetic test. The survey will take you less than 5 minutes to see if you would qualify to take the test.
If you think that you may be at risk for heart disease, cancer, or prescription drug interactions you should take the No-Cost / No-Obligation survey TODAY! 5 minutes may save you, or your children, grandchildren, or sibling’s life!
ALL ABOUT QUALITY
Each and every person is different. Why should we think that all treatment should be the same?
GET INFORMED
We provide you information so you can work with your doctors…people you know and trust!
LAB RELIABLE
We believe in non-invasive testing. Why go under the knife when you can use a swab of the cheek.
GROWN IN THE USA
Often people don’t realize there are tests that can predict their medical future. Learn how.
OUR AREAS OF FOCUS
We focus primarily on three critical areas: cancer, heart, and drug awareness.
The fact that one person dies every 36 seconds in the United States from cardiovascular disease with about 655,000 Americans die from heart disease each year—that’s 1 in every 4 deaths and also the fact that and a total of 1,806,590 new cancer cases and 606,520 deaths are expected in the US in 2020, we know that these genetic tests are critical. When you add those statistics to the studies estimate that 6.7% of hospitalized patients have a serious adverse drug reaction with a fatality rate of 0.32%.
If these drug estimates are correct, then there are more than 2,216,000 serious ADRs in hospitalized patients, causing over 106,000 deaths annually which added to the heart and cancer deaths, is an incredible 1,367,520 people dying yearly, which is one person dying every 23 seconds every day, 365 days per year!
We know from experience if you are aware in advance that you have the propensity for problems in one of these three areas that advanced warning of your possibly having problems in one or more of these areas could make the difference in life and death of not only you but possibly one or more of your children or grandchildren.
Melanoma Cancer
Mutations associated with inherited cardiovascular diseases and sudden cardiac death can be detected through exhaustive Cardiac Genetic Testing. The testing panels include all genes known currently to be associated with the development of inherited cardiovascular diseases that can present as sudden death or other major adverse events. Cardiac Genetic Testing can be ordered in smaller, disease-specific panels or in one comprehensive panel. To learn more about genetic testing services and see if you qualify to receive a test, please click below to fill out our No-Cost, No-Obligation complimentary risk assessment.
Breast Cancer
Cancer genetic testing (CGx) targets the most important genes associated with breast, colon, pancreatic, gynecological and melanoma cancers. These tests are ordered by oncologists, as well as primary care physicians and with patients with at-risk family histories. With Genetic Testing, there is absolutely no reason anyone should wonder or worry if they have potential genetic markers that could indicate potential cancer risk. So why continue to worry? To learn more about our genetic testing services and see if you qualify to receive a test, please click below to fill out our No-Cost, No-Obligation complimentary risk assessment.
Colon Cancer
Genetics account for 20–90% of variability in drug disposition and effects. The pharmacogenetic testing service, PGx Testing, uses a patient’s genes to determine how they will respond to a particular medicine or a combination of medicines and identifies their unique sensitivities to possible drug effects. As a result, healthcare providers can minimize or completely avoid trial-and-error dosing and substantially reduce the risk of potential adverse drug events. To learn more about our genetic testing services and see if you qualify to receive a test, please click below to fill out our No-Cost, No-Obligation complimentary risk assessment.
ARE YOU NEW TO THE CONCEPT OF GENETIC TESTING?
Watch our short and informative video below to see how simple it is to take one of our genetic tests for cancer, heart or drug interaction problems.
